Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing neoplastic progression in ulcerative colitis.

Thomas A Ullman1

  • 1Henry D. Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, New York, NY 10029, USA. thomas.ullman@msnyuhealth.org

Journal of Clinical Gastroenterology
|March 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial Difference in Efficacy of Golimumab in Ulcerative Colitis.

Inflammatory bowel diseases·2022
Same author

Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis.

Gastroenterology clinics of North America·2020
Same author

Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.

Gut and liver·2018
Same author

Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.

Gut·2018
Same author

High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2018
Same author

A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.

Inflammatory bowel diseases·2017

Patients with ulcerative colitis and Crohn's colitis face higher colorectal cancer risks. Current surveillance methods are limited, prompting research into chemoprevention and advanced endoscopic techniques to improve outcomes.

Area of Science:

  • Gastroenterology
  • Oncology
  • Colorectal Cancer Research

Background:

  • Ulcerative colitis (UC) and Crohn's colitis patients have an elevated risk of colorectal cancer (CRC).
  • Risk factors include extensive colitis, disease duration, primary sclerosing cholangitis, family history, young age at onset, and inflammatory burden.
  • Current surveillance strategies for colitis-associated CRC have not proven effective in reducing mortality or morbidity.

Purpose of the Study:

  • To evaluate the effectiveness of current surveillance methods for colorectal cancer in patients with ulcerative colitis and Crohn's colitis.
  • To identify limitations hindering the success of conventional dysplasia surveillance.
  • To explore novel chemoprevention and endoscopic/molecular techniques as potential alternatives or adjuncts to surveillance.

Main Methods:

Related Experiment Videos

  • Review of existing literature on colorectal cancer risk in inflammatory bowel disease.
  • Analysis of factors limiting the efficacy of dysplasia surveillance.
  • Assessment of emerging chemopreventive, endoscopic, and molecular strategies.

Main Results:

  • Several factors compromise surveillance effectiveness, including inter-pathologist variability, patient follow-up issues, and delayed colectomy recommendations.
  • Prophylactic colectomy is an option but often unacceptable to patients.
  • Newer techniques are under investigation to enhance or replace current surveillance.

Conclusions:

  • Effective strategies are needed to mitigate the increased colorectal cancer risk in patients with ulcerative colitis and Crohn's colitis.
  • Limitations in current surveillance necessitate the exploration of alternative and complementary approaches.
  • Chemoprevention and advanced endoscopic/molecular techniques show promise for improving cancer detection and prevention in colitis patients.